AGE|AGE_SPECIFIC_CI_LOWER|AGE_SPECIFIC_CI_UPPER|AGE_SPECIFIC_RATE|COUNT|EVENT_TYPE|POPULATION|SITE|YEAR
1-4|1.8|2.3|2.0|293|Incidence|14396227|Kidney and Renal Pelvis|2002
10-14|0.1|0.2|0.1|22|Incidence|19533296|Kidney and Renal Pelvis|2002
15-19|0.1|0.2|0.1|24|Incidence|18815493|Kidney and Renal Pelvis|2002
5-9|0.4|0.6|0.5|90|Incidence|18503153|Kidney and Renal Pelvis|2002
<1|1.5|2.4|1.9|71|Incidence|3691140|Kidney and Renal Pelvis|2002
1-4|0.5|0.8|0.7|100|Mortality|15324231|Brain and Other Nervous System|2001
10-14|0.5|0.7|0.6|130|Mortality|20892214|Brain and Other Nervous System|2001
15-19|0.4|0.6|0.5|104|Mortality|20305228|Brain and Other Nervous System|2001
5-9|0.7|1.0|0.8|170|Mortality|20234597|Brain and Other Nervous System|2001
<1|0.2|0.6|0.4|16|Mortality|4025926|Brain and Other Nervous System|2001
1-4|20.3|21.8|21.1|3033|Incidence|14396227|All Cancer Sites Combined|2002
10-14|12.2|13.2|12.6|2470|Incidence|19533296|All Cancer Sites Combined|2002
15-19|20.8|22.1|21.5|4038|Incidence|18815493|All Cancer Sites Combined|2002
5-9|11.5|12.5|12.0|2219|Incidence|18503153|All Cancer Sites Combined|2002
<1|23.0|26.2|24.6|907|Incidence|3691140|All Cancer Sites Combined|2002
1-4|~|~|~|~|Mortality|15331809|Hodgkin Lymphoma|2000
10-14|~|~|~|~|Mortality|20620197|Hodgkin Lymphoma|2000
15-19|0.1|0.2|0.1|21|Mortality|20261514|Hodgkin Lymphoma|2000
5-9|~|~|~|~|Mortality|20476523|Hodgkin Lymphoma|2000
<1|~|~|~|~|Mortality|3855642|Hodgkin Lymphoma|2000
1-4|~|~|~|~|Mortality|15551951|Kidney and Renal Pelvis|2002
10-14|~|~|~|~|Mortality|21107836|Kidney and Renal Pelvis|2002
15-19|~|~|~|~|Mortality|20361711|Kidney and Renal Pelvis|2002
5-9|0.1|0.2|0.1|23|Mortality|19976363|Kidney and Renal Pelvis|2002
<1|~|~|~|~|Mortality|3985102|Kidney and Renal Pelvis|2002
1-4|2.3|2.9|2.6|402|Mortality|15551951|All Cancer Sites Combined|2002
10-14|2.3|2.8|2.5|535|Mortality|21107836|All Cancer Sites Combined|2002
15-19|3.3|3.8|3.6|723|Mortality|20361711|All Cancer Sites Combined|2002
5-9|2.5|2.9|2.7|537|Mortality|19976363|All Cancer Sites Combined|2002
<1|1.5|2.3|1.9|74|Mortality|3985102|All Cancer Sites Combined|2002
1-4|0.5|0.7|0.6|83|Incidence|14214314|Non-Hodgkin Lymphoma|2001
10-14|1.1|1.5|1.3|248|Incidence|19360577|Non-Hodgkin Lymphoma|2001
15-19|1.6|1.9|1.7|327|Incidence|18791536|Non-Hodgkin Lymphoma|2001
5-9|0.8|1.1|0.9|176|Incidence|18776213|Non-Hodgkin Lymphoma|2001
<1|~|~|~|~|Incidence|3735453|Non-Hodgkin Lymphoma|2001
1-4|20.8|22.3|21.6|3064|Incidence|14214314|All Cancer Sites Combined|2001
10-14|12.8|13.8|13.3|2567|Incidence|19360577|All Cancer Sites Combined|2001
15-19|20.4|21.7|21.0|3955|Incidence|18791536|All Cancer Sites Combined|2001
5-9|10.9|11.9|11.4|2144|Incidence|18776213|All Cancer Sites Combined|2001
<1|23.3|26.5|24.8|928|Incidence|3735453|All Cancer Sites Combined|2001
1-4|1.8|2.3|2.0|287|Incidence|14042091|Kidney and Renal Pelvis|2000
10-14|0.1|0.2|0.1|24|Incidence|18847598|Kidney and Renal Pelvis|2000
15-19|0.1|0.2|0.1|23|Incidence|18475345|Kidney and Renal Pelvis|2000
5-9|0.5|0.7|0.6|113|Incidence|18755372|Kidney and Renal Pelvis|2000
<1|1.1|1.9|1.5|52|Incidence|3528687|Kidney and Renal Pelvis|2000
1-4|~|~|~|~|Mortality|15324231|Non-Hodgkin Lymphoma|2001
10-14|0.1|0.2|0.1|27|Mortality|20892214|Non-Hodgkin Lymphoma|2001
15-19|0.2|0.4|0.3|61|Mortality|20305228|Non-Hodgkin Lymphoma|2001
5-9|~|~|~|~|Mortality|20234597|Non-Hodgkin Lymphoma|2001
<1|~|~|~|~|Mortality|4025926|Non-Hodgkin Lymphoma|2001
1-4|~|~|~|~|Incidence|14396227|Hodgkin Lymphoma|2002
10-14|1.1|1.4|1.2|236|Incidence|19533296|Hodgkin Lymphoma|2002
15-19|3.0|3.5|3.2|605|Incidence|18815493|Hodgkin Lymphoma|2002
5-9|0.3|0.4|0.3|61|Incidence|18503153|Hodgkin Lymphoma|2002
<1|~|~|~|~|Incidence|3691140|Hodgkin Lymphoma|2002
1-4|2.5|3.0|2.7|420|Mortality|15324231|All Cancer Sites Combined|2001
10-14|2.3|2.7|2.5|515|Mortality|20892214|All Cancer Sites Combined|2001
15-19|3.3|3.9|3.6|732|Mortality|20305228|All Cancer Sites Combined|2001
5-9|2.2|2.7|2.4|493|Mortality|20234597|All Cancer Sites Combined|2001
<1|1.3|2.1|1.6|66|Mortality|4025926|All Cancer Sites Combined|2001
1-4|~|~|~|~|Mortality|15551951|Hodgkin Lymphoma|2002
10-14|~|~|~|~|Mortality|21107836|Hodgkin Lymphoma|2002
15-19|0.1|0.2|0.1|27|Mortality|20361711|Hodgkin Lymphoma|2002
5-9|~|~|~|~|Mortality|19976363|Hodgkin Lymphoma|2002
<1|~|~|~|~|Mortality|3985102|Hodgkin Lymphoma|2002
1-4|~|~|~|~|Mortality|15331809|Kidney and Renal Pelvis|2000
10-14|~|~|~|~|Mortality|20620197|Kidney and Renal Pelvis|2000
15-19|~|~|~|~|Mortality|20261514|Kidney and Renal Pelvis|2000
5-9|0.1|0.2|0.1|21|Mortality|20476523|Kidney and Renal Pelvis|2000
<1|~|~|~|~|Mortality|3855642|Kidney and Renal Pelvis|2000
1-4|3.9|4.6|4.3|616|Incidence|14396227|Brain and Other Nervous System|2002
10-14|2.4|2.9|2.6|511|Incidence|19533296|Brain and Other Nervous System|2002
15-19|1.9|2.4|2.1|403|Incidence|18815493|Brain and Other Nervous System|2002
5-9|3.3|3.8|3.6|657|Incidence|18503153|Brain and Other Nervous System|2002
<1|3.4|4.7|4.0|148|Incidence|3691140|Brain and Other Nervous System|2002
1-4|0.6|0.9|0.7|114|Mortality|15551951|Brain and Other Nervous System|2002
10-14|0.5|0.8|0.6|135|Mortality|21107836|Brain and Other Nervous System|2002
15-19|0.4|0.6|0.5|108|Mortality|20361711|Brain and Other Nervous System|2002
5-9|0.9|1.2|1.0|202|Mortality|19976363|Brain and Other Nervous System|2002
<1|~|~|~|~|Mortality|3985102|Brain and Other Nervous System|2002
1-4|~|~|~|~|Incidence|14042091|Hodgkin Lymphoma|2000
10-14|1.1|1.4|1.3|238|Incidence|18847598|Hodgkin Lymphoma|2000
15-19|2.9|3.4|3.1|575|Incidence|18475345|Hodgkin Lymphoma|2000
5-9|0.3|0.4|0.4|66|Incidence|18755372|Hodgkin Lymphoma|2000
<1|~|~|~|~|Incidence|3528687|Hodgkin Lymphoma|2000
1-4|3.6|4.2|3.9|552|Incidence|14214314|Brain and Other Nervous System|2001
10-14|2.5|2.9|2.7|523|Incidence|19360577|Brain and Other Nervous System|2001
15-19|1.9|2.3|2.1|399|Incidence|18791536|Brain and Other Nervous System|2001
5-9|3.0|3.6|3.3|619|Incidence|18776213|Brain and Other Nervous System|2001
<1|3.1|4.4|3.7|138|Incidence|3735453|Brain and Other Nervous System|2001
1-4|0.6|0.9|0.7|97|Incidence|13822338|Non-Hodgkin Lymphoma|1999
10-14|1.1|1.4|1.2|221|Incidence|18146881|Non-Hodgkin Lymphoma|1999
15-19|1.4|1.7|1.6|279|Incidence|17976823|Non-Hodgkin Lymphoma|1999
5-9|0.7|1.0|0.9|160|Incidence|18557028|Non-Hodgkin Lymphoma|1999
<1|~|~|~|~|Incidence|3417510|Non-Hodgkin Lymphoma|1999
1-4|2.3|2.6|2.4|1947|Mortality|79736756|All Cancer Sites Combined|2002-2006
10-14|2.3|2.5|2.4|2551|Mortality|104849935|All Cancer Sites Combined|2002-2006
15-19|3.3|3.5|3.4|3550|Mortality|103826386|All Cancer Sites Combined|2002-2006
5-9|2.5|2.7|2.6|2523|Mortality|98528471|All Cancer Sites Combined|2002-2006
<1|1.7|2.0|1.8|374|Mortality|20385628|All Cancer Sites Combined|2002-2006
1-4|0.1|0.2|0.1|16|Mortality|15339782|Non-Hodgkin Lymphoma|1999
10-14|0.1|0.2|0.1|25|Mortality|20213364|Non-Hodgkin Lymphoma|1999
15-19|0.2|0.3|0.3|51|Mortality|20084602|Non-Hodgkin Lymphoma|1999
5-9|~|~|~|~|Mortality|20606460|Non-Hodgkin Lymphoma|1999
<1|~|~|~|~|Mortality|3795762|Non-Hodgkin Lymphoma|1999
1-4|~|~|~|~|Incidence|13822338|Hodgkin Lymphoma|1999
10-14|1.0|1.3|1.1|207|Incidence|18146881|Hodgkin Lymphoma|1999
15-19|2.8|3.4|3.1|556|Incidence|17976823|Hodgkin Lymphoma|1999
5-9|0.3|0.5|0.4|73|Incidence|18557028|Hodgkin Lymphoma|1999
<1|~|~|~|~|Incidence|3417510|Hodgkin Lymphoma|1999
1-4|0.5|0.8|0.6|86|Incidence|14042091|Non-Hodgkin Lymphoma|2000
10-14|1.0|1.3|1.1|214|Incidence|18847598|Non-Hodgkin Lymphoma|2000
15-19|1.6|2.0|1.8|329|Incidence|18475345|Non-Hodgkin Lymphoma|2000
5-9|1.0|1.3|1.1|206|Incidence|18755372|Non-Hodgkin Lymphoma|2000
<1|~|~|~|~|Incidence|3528687|Non-Hodgkin Lymphoma|2000
1-4|1.9|2.3|2.1|298|Incidence|14214314|Kidney and Renal Pelvis|2001
10-14|0.1|0.2|0.2|30|Incidence|19360577|Kidney and Renal Pelvis|2001
15-19|0.1|0.2|0.2|30|Incidence|18791536|Kidney and Renal Pelvis|2001
5-9|0.4|0.6|0.5|96|Incidence|18776213|Kidney and Renal Pelvis|2001
<1|1.4|2.3|1.8|67|Incidence|3735453|Kidney and Renal Pelvis|2001
1-4|20.5|21.1|20.8|14975|Incidence|72032406|All Cancer Sites Combined|2002-2006
10-14|12.8|13.2|13.0|12345|Incidence|94924078|All Cancer Sites Combined|2002-2006
15-19|21.4|22.0|21.7|20351|Incidence|93992876|All Cancer Sites Combined|2002-2006
5-9|11.4|11.9|11.6|10376|Incidence|89136197|All Cancer Sites Combined|2002-2006
<1|24.2|25.6|24.9|4581|Incidence|18407240|All Cancer Sites Combined|2002-2006
1-4|0.6|0.7|0.6|505|Mortality|79736756|Brain and Other Nervous System|2002-2006
10-14|0.6|0.7|0.7|700|Mortality|104849935|Brain and Other Nervous System|2002-2006
15-19|0.5|0.6|0.5|556|Mortality|103826386|Brain and Other Nervous System|2002-2006
5-9|0.9|1.0|0.9|927|Mortality|98528471|Brain and Other Nervous System|2002-2006
<1|0.3|0.5|0.4|83|Mortality|20385628|Brain and Other Nervous System|2002-2006
1-4|~|~|~|~|Mortality|15339782|Hodgkin Lymphoma|1999
10-14|~|~|~|~|Mortality|20213364|Hodgkin Lymphoma|1999
15-19|0.1|0.2|0.2|31|Mortality|20084602|Hodgkin Lymphoma|1999
5-9|~|~|~|~|Mortality|20606460|Hodgkin Lymphoma|1999
<1|~|~|~|~|Mortality|3795762|Hodgkin Lymphoma|1999
1-4|0.1|0.1|0.1|67|Mortality|79736756|Kidney and Renal Pelvis|2002-2006
10-14|0.0|0.1|0.0|41|Mortality|104849935|Kidney and Renal Pelvis|2002-2006
15-19|0.0|0.1|0.0|45|Mortality|103826386|Kidney and Renal Pelvis|2002-2006
5-9|0.1|0.1|0.1|117|Mortality|98528471|Kidney and Renal Pelvis|2002-2006
<1|0.1|0.1|0.1|19|Mortality|20385628|Kidney and Renal Pelvis|2002-2006
10-14|0.1|0.2|0.1|23|Incidence|18146881|Kidney and Renal Pelvis|1999
15-19|0.1|0.2|0.2|27|Incidence|17976823|Kidney and Renal Pelvis|1999
5-9|0.4|0.6|0.5|96|Incidence|18557028|Kidney and Renal Pelvis|1999
<1|1.5|2.5|1.9|66|Incidence|3417510|Kidney and Renal Pelvis|1999
1-4|4.0|4.3|4.2|3012|Incidence|72032406|Brain and Other Nervous System|2002-2006
10-14|2.5|2.7|2.6|2476|Incidence|94924078|Brain and Other Nervous System|2002-2006
15-19|2.1|2.3|2.2|2082|Incidence|93992876|Brain and Other Nervous System|2002-2006
5-9|3.2|3.5|3.3|2976|Incidence|89136197|Brain and Other Nervous System|2002-2006
<1|3.5|4.0|3.7|690|Incidence|18407240|Brain and Other Nervous System|2002-2006
1-4|0.1|0.2|0.1|19|Mortality|15339782|Kidney and Renal Pelvis|1999
10-14|~|~|~|~|Mortality|20213364|Kidney and Renal Pelvis|1999
15-19|~|~|~|~|Mortality|20084602|Kidney and Renal Pelvis|1999
5-9|0.1|0.2|0.1|23|Mortality|20606460|Kidney and Renal Pelvis|1999
<1|~|~|~|~|Mortality|3795762|Kidney and Renal Pelvis|1999
1-4|1.9|2.1|2.0|1449|Incidence|72032406|Kidney and Renal Pelvis|2002-2006
10-14|0.1|0.2|0.1|131|Incidence|94924078|Kidney and Renal Pelvis|2002-2006
15-19|0.2|0.2|0.2|167|Incidence|93992876|Kidney and Renal Pelvis|2002-2006
5-9|0.5|0.6|0.5|462|Incidence|89136197|Kidney and Renal Pelvis|2002-2006
<1|1.5|1.8|1.6|301|Incidence|18407240|Kidney and Renal Pelvis|2002-2006
1-4|~|~|~|~|Mortality|15551951|Non-Hodgkin Lymphoma|2002
10-14|0.1|0.3|0.2|42|Mortality|21107836|Non-Hodgkin Lymphoma|2002
15-19|0.2|0.3|0.2|44|Mortality|20361711|Non-Hodgkin Lymphoma|2002
5-9|~|~|~|~|Mortality|19976363|Non-Hodgkin Lymphoma|2002
<1|~|~|~|~|Mortality|3985102|Non-Hodgkin Lymphoma|2002
1-4|1.7|2.2|1.9|266|Incidence|13822338|Kidney and Renal Pelvis|1999
1-4|3.5|4.2|3.9|535|Incidence|13822338|Brain and Other Nervous System|1999
10-14|2.3|2.8|2.6|467|Incidence|18146881|Brain and Other Nervous System|1999
15-19|1.8|2.3|2.1|369|Incidence|17976823|Brain and Other Nervous System|1999
5-9|3.1|3.6|3.3|617|Incidence|18557028|Brain and Other Nervous System|1999
<1|2.8|4.1|3.4|116|Incidence|3417510|Brain and Other Nervous System|1999
1-4|0.6|0.9|0.7|113|Mortality|15339782|Brain and Other Nervous System|1999
10-14|0.5|0.7|0.6|124|Mortality|20213364|Brain and Other Nervous System|1999
15-19|0.5|0.7|0.6|115|Mortality|20084602|Brain and Other Nervous System|1999
5-9|0.8|1.0|0.9|184|Mortality|20606460|Brain and Other Nervous System|1999
<1|~|~|~|~|Mortality|3795762|Brain and Other Nervous System|1999
1-4|0.1|0.1|0.1|66|Incidence|72032406|Hodgkin Lymphoma|2002-2006
10-14|1.1|1.3|1.2|1138|Incidence|94924078|Hodgkin Lymphoma|2002-2006
15-19|3.1|3.3|3.2|3033|Incidence|93992876|Hodgkin Lymphoma|2002-2006
5-9|0.4|0.4|0.4|360|Incidence|89136197|Hodgkin Lymphoma|2002-2006
<1|~|~|~|~|Incidence|18407240|Hodgkin Lymphoma|2002-2006
1-4|~|~|~|~|Mortality|15331809|Non-Hodgkin Lymphoma|2000
10-14|0.1|0.2|0.1|24|Mortality|20620197|Non-Hodgkin Lymphoma|2000
15-19|0.2|0.4|0.3|60|Mortality|20261514|Non-Hodgkin Lymphoma|2000
5-9|0.1|0.2|0.1|23|Mortality|20476523|Non-Hodgkin Lymphoma|2000
<1|~|~|~|~|Mortality|3855642|Non-Hodgkin Lymphoma|2000
1-4|0.6|0.9|0.7|101|Incidence|14396227|Non-Hodgkin Lymphoma|2002
10-14|1.0|1.3|1.1|220|Incidence|19533296|Non-Hodgkin Lymphoma|2002
15-19|1.6|2.0|1.8|332|Incidence|18815493|Non-Hodgkin Lymphoma|2002
5-9|0.8|1.1|1.0|177|Incidence|18503153|Non-Hodgkin Lymphoma|2002
<1|~|~|~|~|Incidence|3691140|Non-Hodgkin Lymphoma|2002
1-4|~|~|~|~|Mortality|79736756|Hodgkin Lymphoma|2002-2006
10-14|0.0|0.0|0.0|24|Mortality|104849935|Hodgkin Lymphoma|2002-2006
15-19|0.1|0.1|0.1|89|Mortality|103826386|Hodgkin Lymphoma|2002-2006
5-9|~|~|~|~|Mortality|98528471|Hodgkin Lymphoma|2002-2006
<1|~|~|~|~|Mortality|20385628|Hodgkin Lymphoma|2002-2006
1-4|0.0|0.1|0.0|35|Mortality|79736756|Non-Hodgkin Lymphoma|2002-2006
10-14|0.1|0.2|0.1|143|Mortality|104849935|Non-Hodgkin Lymphoma|2002-2006
15-19|0.2|0.3|0.2|245|Mortality|103826386|Non-Hodgkin Lymphoma|2002-2006
5-9|0.1|0.1|0.1|84|Mortality|98528471|Non-Hodgkin Lymphoma|2002-2006
<1|~|~|~|~|Mortality|20385628|Non-Hodgkin Lymphoma|2002-2006
1-4|19.1|20.6|19.9|2744|Incidence|13822338|All Cancer Sites Combined|1999
10-14|11.8|12.9|12.3|2239|Incidence|18146881|All Cancer Sites Combined|1999
15-19|19.1|20.4|19.7|3549|Incidence|17976823|All Cancer Sites Combined|1999
5-9|10.6|11.5|11.1|2052|Incidence|18557028|All Cancer Sites Combined|1999
<1|22.3|25.6|23.9|817|Incidence|3417510|All Cancer Sites Combined|1999
1-4|0.1|0.2|0.1|22|Mortality|15324231|Kidney and Renal Pelvis|2001
10-14|~|~|~|~|Mortality|20892214|Kidney and Renal Pelvis|2001
15-19|~|~|~|~|Mortality|20305228|Kidney and Renal Pelvis|2001
5-9|0.1|0.2|0.1|30|Mortality|20234597|Kidney and Renal Pelvis|2001
<1|~|~|~|~|Mortality|4025926|Kidney and Renal Pelvis|2001
1-4|0.6|0.7|0.7|483|Incidence|72032406|Non-Hodgkin Lymphoma|2002-2006
10-14|1.1|1.3|1.2|1139|Incidence|94924078|Non-Hodgkin Lymphoma|2002-2006
15-19|1.7|1.8|1.8|1651|Incidence|93992876|Non-Hodgkin Lymphoma|2002-2006
5-9|0.9|1.0|0.9|841|Incidence|89136197|Non-Hodgkin Lymphoma|2002-2006
<1|0.3|0.5|0.4|65|Incidence|18407240|Non-Hodgkin Lymphoma|2002-2006
1-4|2.5|3.0|2.7|418|Mortality|15339782|All Cancer Sites Combined|1999
10-14|2.3|2.7|2.5|503|Mortality|20213364|All Cancer Sites Combined|1999
15-19|3.4|4.0|3.7|745|Mortality|20084602|All Cancer Sites Combined|1999
5-9|2.3|2.7|2.5|509|Mortality|20606460|All Cancer Sites Combined|1999
<1|1.4|2.3|1.8|68|Mortality|3795762|All Cancer Sites Combined|1999
1-4|19.7|21.1|20.4|3092|Incidence|15151945|All Cancer Sites Combined|2003
10-14|12.3|13.3|12.8|2610|Incidence|20383692|All Cancer Sites Combined|2003
15-19|20.5|21.8|21.1|4159|Incidence|19681033|All Cancer Sites Combined|2003
5-9|10.8|11.7|11.2|2137|Incidence|19012396|All Cancer Sites Combined|2003
<1|23.2|26.4|24.8|962|Incidence|3882968|All Cancer Sites Combined|2003
1-4|2.2|2.7|2.5|392|Mortality|15742383|All Cancer Sites Combined|2003
10-14|2.4|2.9|2.6|560|Mortality|21192613|All Cancer Sites Combined|2003
15-19|3.1|3.6|3.4|690|Mortality|20467671|All Cancer Sites Combined|2003
5-9|2.4|2.8|2.6|516|Mortality|19753885|All Cancer Sites Combined|2003
<1|1.5|2.3|1.9|75|Mortality|4031134|All Cancer Sites Combined|2003
1-4|3.8|4.4|4.1|618|Incidence|15151945|Brain and Other Nervous System|2003
10-14|2.5|2.9|2.7|549|Incidence|20383692|Brain and Other Nervous System|2003
15-19|1.9|2.3|2.1|418|Incidence|19681033|Brain and Other Nervous System|2003
5-9|2.9|3.5|3.2|608|Incidence|19012396|Brain and Other Nervous System|2003
<1|3.1|4.4|3.7|144|Incidence|3882968|Brain and Other Nervous System|2003
1-4|0.5|0.8|0.7|104|Mortality|15742383|Brain and Other Nervous System|2003
10-14|0.6|0.9|0.8|161|Mortality|21192613|Brain and Other Nervous System|2003
15-19|0.5|0.7|0.6|119|Mortality|20467671|Brain and Other Nervous System|2003
5-9|0.8|1.0|0.9|175|Mortality|19753885|Brain and Other Nervous System|2003
<1|0.3|0.7|0.4|18|Mortality|4031134|Brain and Other Nervous System|2003
1-4|0.1|0.2|0.1|19|Incidence|14214314|Hodgkin Lymphoma|2001
10-14|1.0|1.4|1.2|232|Incidence|19360577|Hodgkin Lymphoma|2001
15-19|2.9|3.4|3.2|596|Incidence|18791536|Hodgkin Lymphoma|2001
5-9|0.3|0.5|0.4|82|Incidence|18776213|Hodgkin Lymphoma|2001
<1|~|~|~|~|Incidence|3735453|Hodgkin Lymphoma|2001
1-4|~|~|~|~|Mortality|15324231|Hodgkin Lymphoma|2001
10-14|~|~|~|~|Mortality|20892214|Hodgkin Lymphoma|2001
15-19|0.1|0.2|0.1|25|Mortality|20305228|Hodgkin Lymphoma|2001
5-9|~|~|~|~|Mortality|20234597|Hodgkin Lymphoma|2001
<1|~|~|~|~|Mortality|4025926|Hodgkin Lymphoma|2001
1-4|0.5|0.7|0.6|91|Incidence|15607694|Non-Hodgkin Lymphoma|2006
10-14|1.1|1.4|1.2|240|Incidence|19773006|Non-Hodgkin Lymphoma|2006
15-19|1.6|1.9|1.8|359|Incidence|20449826|Non-Hodgkin Lymphoma|2006
1-4|1.8|2.2|2.0|307|Incidence|15607694|Kidney and Renal Pelvis|2006
10-14|0.1|0.2|0.1|22|Incidence|19773006|Kidney and Renal Pelvis|2006
15-19|0.2|0.3|0.2|47|Incidence|20449826|Kidney and Renal Pelvis|2006
5-9|0.4|0.7|0.5|102|Incidence|18880537|Kidney and Renal Pelvis|2006
5-9|0.7|1.0|0.9|164|Incidence|18880537|Non-Hodgkin Lymphoma|2006
<1|0.3|0.8|0.5|20|Incidence|4007564|Non-Hodgkin Lymphoma|2006
<1|1.3|2.1|1.7|67|Incidence|4007564|Kidney and Renal Pelvis|2006
1-4|19.2|20.6|19.9|3100|Incidence|15607694|All Cancer Sites Combined|2006
10-14|12.5|13.6|13.0|2580|Incidence|19773006|All Cancer Sites Combined|2006
15-19|20.5|21.8|21.1|4322|Incidence|20449826|All Cancer Sites Combined|2006
5-9|11.1|12.0|11.5|2177|Incidence|18880537|All Cancer Sites Combined|2006
<1|23.6|26.7|25.1|1007|Incidence|4007564|All Cancer Sites Combined|2006
1-4|~|~|~|~|Mortality|16272874|Kidney and Renal Pelvis|2006
10-14|~|~|~|~|Mortality|20586946|Kidney and Renal Pelvis|2006
15-19|~|~|~|~|Mortality|21274583|Kidney and Renal Pelvis|2006
1-4|~|~|~|~|Mortality|16272874|Non-Hodgkin Lymphoma|2006
10-14|0.1|0.2|0.1|25|Mortality|20586946|Non-Hodgkin Lymphoma|2006
15-19|0.2|0.3|0.2|45|Mortality|21274583|Non-Hodgkin Lymphoma|2006
5-9|~|~|~|~|Mortality|19673833|Non-Hodgkin Lymphoma|2006
<1|~|~|~|~|Mortality|4178898|Non-Hodgkin Lymphoma|2006
1-4|2.1|2.6|2.3|377|Mortality|16272874|All Cancer Sites Combined|2006
10-14|2.0|2.4|2.2|448|Mortality|20586946|All Cancer Sites Combined|2006
15-19|2.9|3.4|3.2|675|Mortality|21274583|All Cancer Sites Combined|2006
5-9|2.1|2.6|2.3|459|Mortality|19673833|All Cancer Sites Combined|2006
<1|1.4|2.3|1.8|76|Mortality|4178898|All Cancer Sites Combined|2006
5-9|0.1|0.2|0.1|23|Mortality|19673833|Kidney and Renal Pelvis|2006
<1|~|~|~|~|Mortality|4178898|Kidney and Renal Pelvis|2006
1-4|1.8|2.2|2.0|314|Incidence|15917630|Kidney and Renal Pelvis|2005
10-14|0.1|0.2|0.1|27|Incidence|20461017|Kidney and Renal Pelvis|2005
15-19|0.2|0.3|0.2|44|Incidence|20618219|Kidney and Renal Pelvis|2005
5-9|0.4|0.6|0.5|97|Incidence|19173994|Kidney and Renal Pelvis|2005
<1|1.2|2.0|1.6|63|Incidence|4030153|Kidney and Renal Pelvis|2005
1-4|0.1|0.2|0.1|16|Mortality|16200164|Kidney and Renal Pelvis|2005
10-14|~|~|~|~|Mortality|20845086|Kidney and Renal Pelvis|2005
15-19|~|~|~|~|Mortality|21019840|Kidney and Renal Pelvis|2005
5-9|0.1|0.2|0.1|20|Mortality|19525557|Kidney and Renal Pelvis|2005
<1|~|~|~|~|Mortality|4099610|Kidney and Renal Pelvis|2005
1-4|0.4|0.6|0.5|84|Mortality|16200164|Brain and Other Nervous System|2005
10-14|0.5|0.8|0.7|136|Mortality|20845086|Brain and Other Nervous System|2005
15-19|0.5|0.7|0.6|118|Mortality|21019840|Brain and Other Nervous System|2005
5-9|0.8|1.1|1.0|188|Mortality|19525557|Brain and Other Nervous System|2005
<1|0.3|0.7|0.4|18|Mortality|4099610|Brain and Other Nervous System|2005
1-4|0.5|0.8|0.7|105|Incidence|15917630|Non-Hodgkin Lymphoma|2005
10-14|1.1|1.4|1.2|254|Incidence|20461017|Non-Hodgkin Lymphoma|2005
15-19|1.7|2.1|1.9|398|Incidence|20618219|Non-Hodgkin Lymphoma|2005
5-9|0.7|1.0|0.9|166|Incidence|19173994|Non-Hodgkin Lymphoma|2005
<1|0.2|0.7|0.4|17|Incidence|4030153|Non-Hodgkin Lymphoma|2005
1-4|~|~|~|~|Mortality|16200164|Non-Hodgkin Lymphoma|2005
10-14|0.1|0.2|0.1|29|Mortality|20845086|Non-Hodgkin Lymphoma|2005
15-19|0.2|0.3|0.2|47|Mortality|21019840|Non-Hodgkin Lymphoma|2005
5-9|0.1|0.2|0.1|19|Mortality|19525557|Non-Hodgkin Lymphoma|2005
<1|~|~|~|~|Mortality|4099610|Non-Hodgkin Lymphoma|2005
1-4|~|~|~|~|Incidence|15607694|Hodgkin Lymphoma|2006
10-14|1.1|1.4|1.2|245|Incidence|19773006|Hodgkin Lymphoma|2006
15-19|2.9|3.4|3.1|641|Incidence|20449826|Hodgkin Lymphoma|2006
5-9|0.4|0.6|0.5|90|Incidence|18880537|Hodgkin Lymphoma|2006
<1|~|~|~|~|Incidence|4007564|Hodgkin Lymphoma|2006
1-4|19.9|21.3|20.6|3281|Incidence|15917630|All Cancer Sites Combined|2005
10-14|12.4|13.4|12.9|2632|Incidence|20461017|All Cancer Sites Combined|2005
15-19|21.3|22.6|22.0|4529|Incidence|20618219|All Cancer Sites Combined|2005
5-9|11.0|11.9|11.4|2191|Incidence|19173994|All Cancer Sites Combined|2005
<1|22.5|25.5|23.9|965|Incidence|4030153|All Cancer Sites Combined|2005
1-4|~|~|~|~|Mortality|16272874|Hodgkin Lymphoma|2006
10-14|~|~|~|~|Mortality|20586946|Hodgkin Lymphoma|2006
15-19|0.1|0.1|0.1|18|Mortality|21274583|Hodgkin Lymphoma|2006
5-9|~|~|~|~|Mortality|19673833|Hodgkin Lymphoma|2006
<1|~|~|~|~|Mortality|4178898|Hodgkin Lymphoma|2006
1-4|2.1|2.6|2.3|377|Mortality|16200164|All Cancer Sites Combined|2005
10-14|2.3|2.7|2.5|515|Mortality|20845086|All Cancer Sites Combined|2005
15-19|3.2|3.7|3.5|731|Mortality|21019840|All Cancer Sites Combined|2005
5-9|2.3|2.7|2.5|485|Mortality|19525557|All Cancer Sites Combined|2005
<1|1.4|2.3|1.8|75|Mortality|4099610|All Cancer Sites Combined|2005
1-4|0.1|0.2|0.1|16|Incidence|15917630|Hodgkin Lymphoma|2005
10-14|1.1|1.4|1.3|257|Incidence|20461017|Hodgkin Lymphoma|2005
15-19|3.1|3.6|3.3|679|Incidence|20618219|Hodgkin Lymphoma|2005
5-9|0.3|0.5|0.4|75|Incidence|19173994|Hodgkin Lymphoma|2005
<1|~|~|~|~|Incidence|4030153|Hodgkin Lymphoma|2005
1-4|~|~|~|~|Mortality|16200164|Hodgkin Lymphoma|2005
10-14|~|~|~|~|Mortality|20845086|Hodgkin Lymphoma|2005
15-19|~|~|~|~|Mortality|21019840|Hodgkin Lymphoma|2005
5-9|~|~|~|~|Mortality|19525557|Hodgkin Lymphoma|2005
<1|~|~|~|~|Mortality|4099610|Hodgkin Lymphoma|2005
1-4|3.8|4.4|4.1|641|Incidence|15607694|Brain and Other Nervous System|2006
10-14|2.3|2.7|2.5|498|Incidence|19773006|Brain and Other Nervous System|2006
15-19|2.1|2.5|2.3|461|Incidence|20449826|Brain and Other Nervous System|2006
5-9|2.9|3.4|3.1|592|Incidence|18880537|Brain and Other Nervous System|2006
<1|3.0|4.1|3.5|141|Incidence|4007564|Brain and Other Nervous System|2006
1-4|0.5|0.8|0.6|101|Mortality|16272874|Brain and Other Nervous System|2006
10-14|0.5|0.7|0.6|129|Mortality|20586946|Brain and Other Nervous System|2006
15-19|0.4|0.6|0.5|102|Mortality|21274583|Brain and Other Nervous System|2006
5-9|0.8|1.0|0.9|176|Mortality|19673833|Brain and Other Nervous System|2006
<1|0.2|0.6|0.4|16|Mortality|4178898|Brain and Other Nervous System|2006
1-4|~|~|~|~|Incidence|15688413|Hodgkin Lymphoma|2004
10-14|1.0|1.3|1.1|234|Incidence|20724858|Hodgkin Lymphoma|2004
15-19|2.9|3.4|3.1|638|Incidence|20301027|Hodgkin Lymphoma|2004
5-9|0.3|0.4|0.4|68|Incidence|19244948|Hodgkin Lymphoma|2004
<1|~|~|~|~|Incidence|4020211|Hodgkin Lymphoma|2004
1-4|~|~|~|~|Mortality|15969384|Hodgkin Lymphoma|2004
10-14|~|~|~|~|Mortality|21117454|Hodgkin Lymphoma|2004
15-19|0.0|0.1|0.1|17|Mortality|20702581|Hodgkin Lymphoma|2004
5-9|~|~|~|~|Mortality|19598833|Hodgkin Lymphoma|2004
<1|~|~|~|~|Mortality|4090884|Hodgkin Lymphoma|2004
1-4|3.7|4.3|4.0|634|Incidence|15917630|Brain and Other Nervous System|2005
10-14|2.3|2.8|2.5|521|Incidence|20461017|Brain and Other Nervous System|2005
15-19|2.0|2.4|2.2|452|Incidence|20618219|Brain and Other Nervous System|2005
5-9|3.0|3.5|3.2|623|Incidence|19173994|Brain and Other Nervous System|2005
<1|2.9|4.0|3.4|138|Incidence|4030153|Brain and Other Nervous System|2005
1-4|0.5|0.8|0.7|104|Incidence|15688413|Non-Hodgkin Lymphoma|2004
10-14|1.2|1.5|1.3|274|Incidence|20724858|Non-Hodgkin Lymphoma|2004
15-19|1.5|1.8|1.6|330|Incidence|20301027|Non-Hodgkin Lymphoma|2004
5-9|0.8|1.1|0.9|180|Incidence|19244948|Non-Hodgkin Lymphoma|2004
<1|~|~|~|~|Incidence|4020211|Non-Hodgkin Lymphoma|2004
1-4|4.0|4.6|4.3|672|Incidence|15688413|Brain and Other Nervous System|2004
10-14|2.4|2.9|2.6|549|Incidence|20724858|Brain and Other Nervous System|2004
15-19|2.1|2.5|2.3|464|Incidence|20301027|Brain and Other Nervous System|2004
5-9|3.2|3.7|3.5|664|Incidence|19244948|Brain and Other Nervous System|2004
<1|3.5|4.8|4.1|164|Incidence|4020211|Brain and Other Nervous System|2004
1-4|0.5|0.8|0.6|102|Mortality|15969384|Brain and Other Nervous System|2004
10-14|0.6|0.8|0.7|139|Mortality|21117454|Brain and Other Nervous System|2004
15-19|0.4|0.6|0.5|109|Mortality|20702581|Brain and Other Nervous System|2004
5-9|0.8|1.1|0.9|186|Mortality|19598833|Brain and Other Nervous System|2004
1-4|0.1|0.2|0.1|18|Incidence|15151945|Hodgkin Lymphoma|2003
10-14|1.0|1.3|1.2|238|Incidence|20383692|Hodgkin Lymphoma|2003
15-19|3.0|3.5|3.2|630|Incidence|19681033|Hodgkin Lymphoma|2003
5-9|0.4|0.5|0.4|84|Incidence|19012396|Hodgkin Lymphoma|2003
<1|~|~|~|~|Incidence|3882968|Hodgkin Lymphoma|2003
<1|0.3|0.7|0.5|19|Mortality|4090884|Brain and Other Nervous System|2004
1-4|~|~|~|~|Mortality|15969384|Non-Hodgkin Lymphoma|2004
10-14|0.1|0.1|0.1|19|Mortality|21117454|Non-Hodgkin Lymphoma|2004
15-19|0.2|0.4|0.3|56|Mortality|20702581|Non-Hodgkin Lymphoma|2004
5-9|0.1|0.2|0.1|22|Mortality|19598833|Non-Hodgkin Lymphoma|2004
<1|~|~|~|~|Mortality|4090884|Non-Hodgkin Lymphoma|2004
1-4|1.8|2.3|2.1|322|Incidence|15688413|Kidney and Renal Pelvis|2004
10-14|0.1|0.2|0.2|35|Incidence|20724858|Kidney and Renal Pelvis|2004
15-19|0.1|0.3|0.2|39|Incidence|20301027|Kidney and Renal Pelvis|2004
5-9|0.4|0.6|0.5|92|Incidence|19244948|Kidney and Renal Pelvis|2004
<1|1.0|1.7|1.3|52|Incidence|4020211|Kidney and Renal Pelvis|2004
1-4|0.1|0.2|0.1|18|Mortality|15969384|Kidney and Renal Pelvis|2004
10-14|~|~|~|~|Mortality|21117454|Kidney and Renal Pelvis|2004
15-19|~|~|~|~|Mortality|20702581|Kidney and Renal Pelvis|2004
5-9|0.1|0.2|0.1|23|Mortality|19598833|Kidney and Renal Pelvis|2004
<1|~|~|~|~|Mortality|4090884|Kidney and Renal Pelvis|2004
1-4|~|~|~|~|Mortality|15742383|Hodgkin Lymphoma|2003
10-14|~|~|~|~|Mortality|21192613|Hodgkin Lymphoma|2003
15-19|0.0|0.1|0.1|16|Mortality|20467671|Hodgkin Lymphoma|2003
5-9|~|~|~|~|Mortality|19753885|Hodgkin Lymphoma|2003
<1|~|~|~|~|Mortality|4031134|Hodgkin Lymphoma|2003
1-4|20.9|22.4|21.7|3400|Incidence|15688413|All Cancer Sites Combined|2004
10-14|12.9|13.9|13.4|2767|Incidence|20724858|All Cancer Sites Combined|2004
15-19|20.9|22.2|21.6|4378|Incidence|20301027|All Cancer Sites Combined|2004
5-9|11.2|12.2|11.7|2256|Incidence|19244948|All Cancer Sites Combined|2004
<1|23.9|27.0|25.4|1022|Incidence|4020211|All Cancer Sites Combined|2004
1-4|2.3|2.8|2.5|399|Mortality|15969384|All Cancer Sites Combined|2004
10-14|2.1|2.6|2.3|493|Mortality|21117454|All Cancer Sites Combined|2004
15-19|3.3|3.8|3.5|731|Mortality|20702581|All Cancer Sites Combined|2004
5-9|2.5|2.9|2.7|526|Mortality|19598833|All Cancer Sites Combined|2004
<1|1.4|2.3|1.8|74|Mortality|4090884|All Cancer Sites Combined|2004
1-4|0.6|0.9|0.7|112|Incidence|15151945|Non-Hodgkin Lymphoma|2003
10-14|0.9|1.2|1.0|211|Incidence|20383692|Non-Hodgkin Lymphoma|2003
15-19|1.4|1.8|1.6|318|Incidence|19681033|Non-Hodgkin Lymphoma|2003
5-9|0.9|1.2|1.0|191|Incidence|19012396|Non-Hodgkin Lymphoma|2003
<1|~|~|~|~|Incidence|3882968|Non-Hodgkin Lymphoma|2003
1-4|~|~|~|~|Mortality|15742383|Non-Hodgkin Lymphoma|2003
10-14|0.1|0.2|0.1|28|Mortality|21192613|Non-Hodgkin Lymphoma|2003
15-19|0.2|0.3|0.3|53|Mortality|20467671|Non-Hodgkin Lymphoma|2003
5-9|0.1|0.1|0.1|17|Mortality|19753885|Non-Hodgkin Lymphoma|2003
<1|~|~|~|~|Mortality|4031134|Non-Hodgkin Lymphoma|2003
1-4|1.7|2.2|2.0|298|Incidence|15151945|Kidney and Renal Pelvis|2003
10-14|0.1|0.2|0.2|31|Incidence|20383692|Kidney and Renal Pelvis|2003
15-19|0.1|0.2|0.1|29|Incidence|19681033|Kidney and Renal Pelvis|2003
5-9|0.4|0.6|0.5|98|Incidence|19012396|Kidney and Renal Pelvis|2003
<1|1.4|2.2|1.8|68|Incidence|3882968|Kidney and Renal Pelvis|2003
1-4|~|~|~|~|Mortality|15742383|Kidney and Renal Pelvis|2003
10-14|~|~|~|~|Mortality|21192613|Kidney and Renal Pelvis|2003
15-19|~|~|~|~|Mortality|20467671|Kidney and Renal Pelvis|2003
5-9|0.1|0.2|0.1|28|Mortality|19753885|Kidney and Renal Pelvis|2003
<1|~|~|~|~|Mortality|4031134|Kidney and Renal Pelvis|2003
1-4|3.7|4.4|4.1|572|Incidence|14042091|Brain and Other Nervous System|2000
10-14|2.5|3.0|2.7|513|Incidence|18847598|Brain and Other Nervous System|2000
15-19|2.0|2.4|2.2|404|Incidence|18475345|Brain and Other Nervous System|2000
5-9|3.1|3.6|3.3|626|Incidence|18755372|Brain and Other Nervous System|2000
<1|3.4|4.7|4.0|141|Incidence|3528687|Brain and Other Nervous System|2000
1-4|0.6|0.8|0.7|104|Mortality|15331809|Brain and Other Nervous System|2000
10-14|0.6|0.9|0.7|150|Mortality|20620197|Brain and Other Nervous System|2000
15-19|0.4|0.6|0.5|105|Mortality|20261514|Brain and Other Nervous System|2000
5-9|0.7|0.9|0.8|166|Mortality|20476523|Brain and Other Nervous System|2000
<1|0.3|0.8|0.5|20|Mortality|3855642|Brain and Other Nervous System|2000
1-4|19.6|21.0|20.3|2849|Incidence|14042091|All Cancer Sites Combined|2000
10-14|11.8|12.8|12.3|2313|Incidence|18847598|All Cancer Sites Combined|2000
15-19|19.7|21.0|20.4|3763|Incidence|18475345|All Cancer Sites Combined|2000
5-9|11.0|12.0|11.5|2153|Incidence|18755372|All Cancer Sites Combined|2000
<1|21.9|25.1|23.4|827|Incidence|3528687|All Cancer Sites Combined|2000
1-4|2.5|3.0|2.7|420|Mortality|15331809|All Cancer Sites Combined|2000
10-14|2.3|2.8|2.5|525|Mortality|20620197|All Cancer Sites Combined|2000
15-19|3.4|4.0|3.7|745|Mortality|20261514|All Cancer Sites Combined|2000
5-9|2.2|2.6|2.4|489|Mortality|20476523|All Cancer Sites Combined|2000
<1|1.9|2.9|2.4|92|Mortality|3855642|All Cancer Sites Combined|2000
1-4|0.6|0.9|0.8|124|Mortality|16272874|Leukemia|2006
10-14|0.6|0.9|0.7|152|Mortality|20586946|Leukemia|2006
15-19|0.8|1.1|1.0|207|Mortality|21274583|Leukemia|2006
5-9|0.4|0.6|0.5|104|Mortality|19673833|Leukemia|2006
<1|0.5|1.1|0.7|31|Mortality|4178898|Leukemia|2006
1-4|7.8|8.7|8.2|1285|Incidence|15607694|Leukemia|2006
10-14|2.9|3.4|3.1|617|Incidence|19773006|Leukemia|2006
15-19|2.7|3.2|2.9|600|Incidence|20449826|Leukemia|2006
5-9|3.4|4.0|3.7|695|Incidence|18880537|Leukemia|2006
<1|3.8|5.1|4.4|176|Incidence|4007564|Leukemia|2006
1-4|0.5|0.8|0.7|108|Mortality|16272874|Other|2006
10-14|0.3|0.4|0.3|68|Mortality|20586946|Other|2006
15-19|0.5|0.7|0.5|117|Mortality|21274583|Other|2006
5-9|0.4|0.6|0.5|96|Mortality|19673833|Other|2006
<1|0.4|0.9|0.6|24|Mortality|4178898|Other|2006
1-4|3.4|4.0|3.7|573|Incidence|15607694|Other|2006
10-14|2.5|3.0|2.7|542|Incidence|19773006|Other|2006
15-19|7.8|8.6|8.2|1670|Incidence|20449826|Other|2006
5-9|1.4|1.8|1.6|300|Incidence|18880537|Other|2006
<1|10.9|13.0|11.9|478|Incidence|4007564|Other|2006
1-4|0.1|0.2|0.1|23|Mortality|16272874|Soft Tissue|2006
10-14|0.1|0.2|0.1|25|Mortality|20586946|Soft Tissue|2006
15-19|0.2|0.4|0.3|60|Mortality|21274583|Soft Tissue|2006
5-9|0.1|0.2|0.2|31|Mortality|19673833|Soft Tissue|2006
<1|~|~|~|~|Mortality|4178898|Soft Tissue|2006
1-4|0.9|1.2|1.1|167|Incidence|15607694|Soft Tissue|2006
10-14|0.7|1.0|0.9|169|Incidence|19773006|Soft Tissue|2006
15-19|0.9|1.2|1.1|217|Incidence|20449826|Soft Tissue|2006
5-9|0.5|0.7|0.6|105|Incidence|18880537|Soft Tissue|2006
<1|2.4|3.5|2.9|116|Incidence|4007564|Soft Tissue|2006
1-4|~|~|~|~|Mortality|16272874|Bones and Joints|2006
10-14|0.1|0.2|0.2|37|Mortality|20586946|Bones and Joints|2006
15-19|0.4|0.6|0.5|115|Mortality|21274583|Bones and Joints|2006
5-9|0.1|0.1|0.1|18|Mortality|19673833|Bones and Joints|2006
<1|~|~|~|~|Mortality|4178898|Bones and Joints|2006
1-4|0.1|0.2|0.1|21|Incidence|15607694|Bones and Joints|2006
10-14|1.1|1.4|1.2|247|Incidence|19773006|Bones and Joints|2006
15-19|1.4|1.8|1.6|327|Incidence|20449826|Bones and Joints|2006
5-9|0.6|0.8|0.7|129|Incidence|18880537|Bones and Joints|2006
<1|~|~|~|~|Incidence|4007564|Bones and Joints|2006
1-4|8.2|8.6|8.4|6050|Incidence|72032406|Leukemia|2002-2006
10-14|2.7|2.9|2.8|2690|Incidence|94924078|Leukemia|2002-2006
15-19|2.7|2.9|2.8|2666|Incidence|93992876|Leukemia|2002-2006
5-9|3.7|3.9|3.8|3370|Incidence|89136197|Leukemia|2002-2006
<1|4.0|4.6|4.3|789|Incidence|18407240|Leukemia|2002-2006
1-4|4.0|4.7|4.3|689|Incidence|15917630|Other|2005
10-14|2.6|3.0|2.8|575|Incidence|20461017|Other|2005
15-19|8.5|9.4|8.9|1842|Incidence|20618219|Other|2005
5-9|1.4|1.8|1.6|302|Incidence|19173994|Other|2005
<1|9.6|11.6|10.5|425|Incidence|4030153|Other|2005
1-4|0.1|0.2|0.1|21|Mortality|16200164|Soft Tissue|2005
10-14|0.1|0.2|0.2|35|Mortality|20845086|Soft Tissue|2005
15-19|0.3|0.5|0.4|80|Mortality|21019840|Soft Tissue|2005
5-9|0.1|0.2|0.1|21|Mortality|19525557|Soft Tissue|2005
<1|~|~|~|~|Mortality|4099610|Soft Tissue|2005
1-4|0.7|0.8|0.8|619|Mortality|79736756|Other|2002-2006
10-14|0.3|0.4|0.3|366|Mortality|104849935|Other|2002-2006
1-4|0.8|1.2|1.0|158|Incidence|15917630|Soft Tissue|2005
10-14|0.7|0.9|0.8|159|Incidence|20461017|Soft Tissue|2005
15-19|1.0|1.3|1.1|237|Incidence|20618219|Soft Tissue|2005
5-9|0.5|0.8|0.6|122|Incidence|19173994|Soft Tissue|2005
<1|3.0|4.2|3.6|145|Incidence|4030153|Soft Tissue|2005
15-19|0.6|0.7|0.6|672|Mortality|103826386|Other|2002-2006
5-9|0.4|0.5|0.5|482|Mortality|98528471|Other|2002-2006
<1|0.5|0.7|0.6|117|Mortality|20385628|Other|2002-2006
1-4|4.0|4.3|4.2|3005|Incidence|72032406|Other|2002-2006
1-4|0.2|0.4|0.3|44|Mortality|16272874|Acute Lymphocytic|2006
10-14|0.3|0.4|0.3|69|Mortality|20586946|Acute Lymphocytic|2006
15-19|0.3|0.5|0.4|92|Mortality|21274583|Acute Lymphocytic|2006
5-9|0.2|0.3|0.3|52|Mortality|19673833|Acute Lymphocytic|2006
<1|~|~|~|~|Mortality|4178898|Acute Lymphocytic|2006
10-14|2.7|2.9|2.8|2667|Incidence|94924078|Other|2002-2006
15-19|8.6|8.9|8.7|8224|Incidence|93992876|Other|2002-2006
5-9|1.4|1.6|1.5|1358|Incidence|89136197|Other|2002-2006
<1|11.0|12.0|11.5|2108|Incidence|18407240|Other|2002-2006
1-4|0.1|0.2|0.1|18|Mortality|15339782|Soft Tissue|1999
10-14|0.1|0.3|0.2|37|Mortality|20213364|Soft Tissue|1999
15-19|0.2|0.4|0.3|65|Mortality|20084602|Soft Tissue|1999
5-9|0.1|0.2|0.1|28|Mortality|20606460|Soft Tissue|1999
<1|~|~|~|~|Mortality|3795762|Soft Tissue|1999
1-4|6.6|7.4|7.0|1087|Incidence|15607694|Acute Lymphocytic|2006
10-14|2.0|2.4|2.2|427|Incidence|19773006|Acute Lymphocytic|2006
15-19|1.4|1.8|1.6|325|Incidence|20449826|Acute Lymphocytic|2006
5-9|2.8|3.3|3.1|583|Incidence|18880537|Acute Lymphocytic|2006
<1|1.7|2.6|2.1|84|Incidence|4007564|Acute Lymphocytic|2006
1-4|0.1|0.2|0.1|104|Mortality|79736756|Soft Tissue|2002-2006
10-14|0.1|0.2|0.2|179|Mortality|104849935|Soft Tissue|2002-2006
15-19|0.3|0.4|0.3|332|Mortality|103826386|Soft Tissue|2002-2006
5-9|0.1|0.2|0.1|134|Mortality|98528471|Soft Tissue|2002-2006
<1|0.0|0.1|0.1|17|Mortality|20385628|Soft Tissue|2002-2006
1-4|0.8|1.1|0.9|129|Incidence|13822338|Soft Tissue|1999
10-14|0.6|0.8|0.7|124|Incidence|18146881|Soft Tissue|1999
15-19|0.8|1.1|1.0|171|Incidence|17976823|Soft Tissue|1999
5-9|0.4|0.6|0.5|98|Incidence|18557028|Soft Tissue|1999
<1|2.4|3.6|3.0|102|Incidence|3417510|Soft Tissue|1999
1-4|0.2|0.4|0.3|54|Mortality|16272874|Acute Myeloid|2006
10-14|0.1|0.3|0.2|42|Mortality|20586946|Acute Myeloid|2006
15-19|0.3|0.4|0.3|71|Mortality|21274583|Acute Myeloid|2006
1-4|0.2|0.4|0.3|48|Mortality|15331809|Acute Lymphocytic|2000
10-14|0.4|0.5|0.4|92|Mortality|20620197|Acute Lymphocytic|2000
15-19|0.4|0.6|0.5|98|Mortality|20261514|Acute Lymphocytic|2000
5-9|0.3|0.5|0.4|78|Mortality|20476523|Acute Lymphocytic|2000
<1|0.2|0.7|0.4|16|Mortality|3855642|Acute Lymphocytic|2000
1-4|1.0|1.2|1.1|776|Incidence|72032406|Soft Tissue|2002-2006
10-14|0.8|0.9|0.9|828|Incidence|94924078|Soft Tissue|2002-2006
15-19|1.1|1.2|1.2|1081|Incidence|93992876|Soft Tissue|2002-2006
5-9|0.5|0.6|0.6|500|Incidence|89136197|Soft Tissue|2002-2006
<1|3.0|3.5|3.2|596|Incidence|18407240|Soft Tissue|2002-2006
1-4|6.8|7.7|7.2|1013|Incidence|14042091|Acute Lymphocytic|2000
10-14|1.5|1.9|1.7|323|Incidence|18847598|Acute Lymphocytic|2000
15-19|1.5|1.8|1.6|302|Incidence|18475345|Acute Lymphocytic|2000
5-9|2.9|3.4|3.2|594|Incidence|18755372|Acute Lymphocytic|2000
<1|1.9|2.9|2.4|83|Incidence|3528687|Acute Lymphocytic|2000
1-4|0.3|0.5|0.4|61|Mortality|15742383|Acute Lymphocytic|2003
10-14|0.3|0.5|0.4|87|Mortality|21192613|Acute Lymphocytic|2003
15-19|0.3|0.5|0.4|82|Mortality|20467671|Acute Lymphocytic|2003
5-9|0.4|0.5|0.4|87|Mortality|19753885|Acute Lymphocytic|2003
<1|~|~|~|~|Mortality|4031134|Acute Lymphocytic|2003
1-4|6.3|7.2|6.7|1020|Incidence|15151945|Acute Lymphocytic|2003
10-14|1.6|1.9|1.7|355|Incidence|20383692|Acute Lymphocytic|2003
15-19|1.3|1.6|1.4|281|Incidence|19681033|Acute Lymphocytic|2003
1-4|0.0|0.0|0.0|16|Mortality|79736756|Bones and Joints|2002-2006
10-14|0.2|0.3|0.3|286|Mortality|104849935|Bones and Joints|2002-2006
15-19|0.5|0.6|0.5|551|Mortality|103826386|Bones and Joints|2002-2006
5-9|0.1|0.1|0.1|81|Mortality|98528471|Bones and Joints|2002-2006
<1|~|~|~|~|Mortality|20385628|Bones and Joints|2002-2006
1-4|0.2|0.2|0.2|134|Incidence|72032406|Bones and Joints|2002-2006
10-14|1.3|1.4|1.3|1276|Incidence|94924078|Bones and Joints|2002-2006
15-19|1.5|1.6|1.5|1447|Incidence|93992876|Bones and Joints|2002-2006
5-9|0.5|0.6|0.6|509|Incidence|89136197|Bones and Joints|2002-2006
<1|0.1|0.2|0.2|32|Incidence|18407240|Bones and Joints|2002-2006
1-4|0.3|0.5|0.4|56|Mortality|15331809|Acute Myeloid|2000
10-14|0.2|0.3|0.2|47|Mortality|20620197|Acute Myeloid|2000
15-19|0.3|0.5|0.4|77|Mortality|20261514|Acute Myeloid|2000
5-9|0.1|0.2|0.2|33|Mortality|20476523|Acute Myeloid|2000
<1|~|~|~|~|Mortality|3855642|Acute Myeloid|2000
<1|~|~|~|~|Incidence|3417510|Bones and Joints|1999
5-9|0.1|0.1|0.1|17|Mortality|19673833|Acute Myeloid|2006
<1|~|~|~|~|Mortality|4178898|Acute Myeloid|2006
1-4|0.7|1.0|0.9|138|Incidence|15607694|Acute Myeloid|2006
10-14|0.6|0.8|0.7|132|Incidence|19773006|Acute Myeloid|2006
15-19|0.7|1.0|0.8|167|Incidence|20449826|Acute Myeloid|2006
5-9|0.3|0.5|0.4|70|Incidence|18880537|Acute Myeloid|2006
<1|0.9|1.6|1.2|47|Incidence|4007564|Acute Myeloid|2006
1-4|0.6|0.9|0.7|120|Mortality|16200164|Leukemia|2005
10-14|0.6|0.8|0.7|150|Mortality|20845086|Leukemia|2005
15-19|0.9|1.2|1.1|223|Mortality|21019840|Leukemia|2005
5-9|0.5|0.8|0.6|125|Mortality|19525557|Leukemia|2005
<1|0.3|0.8|0.5|22|Mortality|4099610|Leukemia|2005
1-4|0.6|0.9|0.8|119|Mortality|15339782|Leukemia|1999
10-14|0.7|1.0|0.9|175|Mortality|20213364|Leukemia|1999
15-19|1.0|1.3|1.1|221|Mortality|20084602|Leukemia|1999
5-9|0.5|0.7|0.6|130|Mortality|20606460|Leukemia|1999
<1|0.5|1.0|0.7|27|Mortality|3795762|Leukemia|1999
1-4|7.9|8.8|8.4|1333|Incidence|15917630|Leukemia|2005
10-14|2.6|3.1|2.8|582|Incidence|20461017|Leukemia|2005
15-19|2.5|3.0|2.8|568|Incidence|20618219|Leukemia|2005
5-9|3.4|3.9|3.6|694|Incidence|19173994|Leukemia|2005
<1|3.6|4.9|4.2|170|Incidence|4030153|Leukemia|2005
1-4|7.7|8.7|8.2|1132|Incidence|13822338|Leukemia|1999
10-14|2.6|3.1|2.8|512|Incidence|18146881|Leukemia|1999
15-19|2.5|3.0|2.7|488|Incidence|17976823|Leukemia|1999
5-9|3.4|4.0|3.7|690|Incidence|18557028|Leukemia|1999
<1|3.8|5.2|4.4|152|Incidence|3417510|Leukemia|1999
1-4|0.2|0.4|0.3|44|Mortality|15339782|Acute Lymphocytic|1999
10-14|0.3|0.5|0.4|75|Mortality|20213364|Acute Lymphocytic|1999
15-19|0.4|0.6|0.5|91|Mortality|20084602|Acute Lymphocytic|1999
5-9|0.2|0.4|0.3|65|Mortality|20606460|Acute Lymphocytic|1999
<1|~|~|~|~|Mortality|3795762|Acute Lymphocytic|1999
1-4|6.4|7.3|6.8|942|Incidence|13822338|Acute Lymphocytic|1999
10-14|1.8|2.2|2.0|361|Incidence|18146881|Acute Lymphocytic|1999
15-19|1.2|1.6|1.4|252|Incidence|17976823|Acute Lymphocytic|1999
5-9|2.8|3.3|3.0|565|Incidence|18557028|Acute Lymphocytic|1999
<1|1.7|2.7|2.2|74|Incidence|3417510|Acute Lymphocytic|1999
1-4|0.7|0.9|0.8|127|Mortality|16200164|Other|2005
10-14|0.3|0.5|0.4|82|Mortality|20845086|Other|2005
15-19|0.5|0.7|0.6|120|Mortality|21019840|Other|2005
5-9|0.4|0.6|0.5|90|Mortality|19525557|Other|2005
<1|0.3|0.7|0.5|19|Mortality|4099610|Other|2005
1-4|6.7|7.5|7.1|1133|Incidence|15917630|Acute Lymphocytic|2005
10-14|1.7|2.1|1.9|383|Incidence|20461017|Acute Lymphocytic|2005
15-19|1.4|1.7|1.6|321|Incidence|20618219|Acute Lymphocytic|2005
5-9|2.8|3.3|3.1|587|Incidence|19173994|Acute Lymphocytic|2005
<1|1.5|2.4|1.9|77|Incidence|4030153|Acute Lymphocytic|2005
1-4|0.7|0.8|0.8|601|Mortality|79736756|Leukemia|2002-2006
10-14|0.7|0.8|0.8|812|Mortality|104849935|Leukemia|2002-2006
15-19|1.0|1.1|1.0|1060|Mortality|103826386|Leukemia|2002-2006
5-9|0.6|0.8|0.7|689|Mortality|98528471|Leukemia|2002-2006
<1|0.5|0.7|0.6|127|Mortality|20385628|Leukemia|2002-2006
1-4|0.2|0.4|0.3|50|Mortality|15339782|Acute Myeloid|1999
10-14|0.2|0.3|0.3|54|Mortality|20213364|Acute Myeloid|1999
15-19|0.3|0.4|0.3|66|Mortality|20084602|Acute Myeloid|1999
5-9|0.1|0.2|0.1|29|Mortality|20606460|Acute Myeloid|1999
<1|~|~|~|~|Mortality|3795762|Acute Myeloid|1999
1-4|0.3|0.5|0.4|60|Mortality|16200164|Acute Myeloid|2005
10-14|0.2|0.3|0.2|44|Mortality|20845086|Acute Myeloid|2005
15-19|0.3|0.4|0.4|75|Mortality|21019840|Acute Myeloid|2005
5-9|0.1|0.2|0.1|29|Mortality|19525557|Acute Myeloid|2005
<1|~|~|~|~|Mortality|4099610|Acute Myeloid|2005
1-4|0.1|0.2|0.1|23|Mortality|15551951|Soft Tissue|2002
10-14|0.1|0.3|0.2|41|Mortality|21107836|Soft Tissue|2002
15-19|0.2|0.4|0.3|58|Mortality|20361711|Soft Tissue|2002
5-9|0.1|0.2|0.1|28|Mortality|19976363|Soft Tissue|2002
<1|~|~|~|~|Mortality|3985102|Soft Tissue|2002
1-4|0.7|1.0|0.8|133|Incidence|15917630|Acute Myeloid|2005
10-14|0.5|0.7|0.6|120|Incidence|20461017|Acute Myeloid|2005
15-19|0.6|0.8|0.7|149|Incidence|20618219|Acute Myeloid|2005
5-9|0.3|0.5|0.4|69|Incidence|19173994|Acute Myeloid|2005
<1|0.9|1.7|1.3|51|Incidence|4030153|Acute Myeloid|2005
1-4|0.8|1.2|1.0|137|Incidence|13822338|Acute Myeloid|1999
10-14|0.5|0.7|0.6|105|Incidence|18146881|Acute Myeloid|1999
15-19|0.8|1.0|0.9|159|Incidence|17976823|Acute Myeloid|1999
5-9|0.4|0.6|0.5|89|Incidence|18557028|Acute Myeloid|1999
<1|0.9|1.6|1.2|41|Incidence|3417510|Acute Myeloid|1999
1-4|1.0|1.4|1.2|174|Incidence|14396227|Soft Tissue|2002
10-14|0.7|1.0|0.8|163|Incidence|19533296|Soft Tissue|2002
15-19|0.9|1.2|1.1|200|Incidence|18815493|Soft Tissue|2002
5-9|0.5|0.8|0.6|119|Incidence|18503153|Soft Tissue|2002
<1|2.6|3.8|3.2|118|Incidence|3691140|Soft Tissue|2002
1-4|0.2|0.3|0.3|222|Mortality|79736756|Acute Lymphocytic|2002-2006
10-14|0.3|0.4|0.4|398|Mortality|104849935|Acute Lymphocytic|2002-2006
15-19|0.4|0.5|0.4|452|Mortality|103826386|Acute Lymphocytic|2002-2006
5-9|0.3|0.4|0.4|368|Mortality|98528471|Acute Lymphocytic|2002-2006
<1|0.1|0.3|0.2|39|Mortality|20385628|Acute Lymphocytic|2002-2006
1-4|6.9|7.3|7.1|5104|Incidence|72032406|Acute Lymphocytic|2002-2006
10-14|1.8|2.0|1.9|1793|Incidence|94924078|Acute Lymphocytic|2002-2006
15-19|1.5|1.6|1.6|1473|Incidence|93992876|Acute Lymphocytic|2002-2006
5-9|3.0|3.3|3.1|2793|Incidence|89136197|Acute Lymphocytic|2002-2006
<1|1.7|2.1|1.9|354|Incidence|18407240|Acute Lymphocytic|2002-2006
1-4|~|~|~|~|Mortality|16200164|Bones and Joints|2005
10-14|0.2|0.4|0.3|67|Mortality|20845086|Bones and Joints|2005
15-19|0.5|0.7|0.6|124|Mortality|21019840|Bones and Joints|2005
5-9|0.1|0.1|0.1|17|Mortality|19525557|Bones and Joints|2005
<1|~|~|~|~|Mortality|4099610|Bones and Joints|2005
1-4|~|~|~|~|Mortality|15339782|Bones and Joints|1999
10-14|0.2|0.4|0.3|55|Mortality|20213364|Bones and Joints|1999
15-19|0.5|0.8|0.6|127|Mortality|20084602|Bones and Joints|1999
5-9|0.1|0.2|0.1|24|Mortality|20606460|Bones and Joints|1999
<1|~|~|~|~|Mortality|3795762|Bones and Joints|1999
1-4|0.3|0.4|0.3|253|Mortality|79736756|Acute Myeloid|2002-2006
10-14|0.2|0.3|0.2|235|Mortality|104849935|Acute Myeloid|2002-2006
15-19|0.3|0.4|0.3|353|Mortality|103826386|Acute Myeloid|2002-2006
5-9|0.1|0.2|0.2|154|Mortality|98528471|Acute Myeloid|2002-2006
<1|0.1|0.3|0.2|39|Mortality|20385628|Acute Myeloid|2002-2006
1-4|0.1|0.3|0.2|32|Incidence|15917630|Bones and Joints|2005
10-14|1.1|1.4|1.3|257|Incidence|20461017|Bones and Joints|2005
15-19|1.3|1.7|1.5|309|Incidence|20618219|Bones and Joints|2005
5-9|0.5|0.7|0.6|112|Incidence|19173994|Bones and Joints|2005
<1|~|~|~|~|Incidence|4030153|Bones and Joints|2005
1-4|0.8|0.9|0.8|608|Incidence|72032406|Acute Myeloid|2002-2006
10-14|0.6|0.7|0.6|614|Incidence|94924078|Acute Myeloid|2002-2006
15-19|0.8|0.9|0.8|762|Incidence|93992876|Acute Myeloid|2002-2006
5-9|0.4|0.4|0.4|358|Incidence|89136197|Acute Myeloid|2002-2006
<1|1.2|1.5|1.3|243|Incidence|18407240|Acute Myeloid|2002-2006
1-4|0.6|0.9|0.8|120|Mortality|15969384|Leukemia|2004
10-14|0.6|0.9|0.7|156|Mortality|21117454|Leukemia|2004
15-19|0.9|1.2|1.0|210|Mortality|20702581|Leukemia|2004
5-9|0.7|0.9|0.8|156|Mortality|19598833|Leukemia|2004
<1|0.4|0.8|0.6|23|Mortality|4090884|Leukemia|2004
1-4|8.5|9.4|8.9|1402|Incidence|15688413|Leukemia|2004
10-14|2.6|3.0|2.8|581|Incidence|20724858|Leukemia|2004
1-4|0.5|0.8|0.7|104|Mortality|15551951|Leukemia|2002
10-14|0.7|0.9|0.8|168|Mortality|21107836|Leukemia|2002
15-19|1.0|1.3|1.2|237|Mortality|20361711|Leukemia|2002
5-9|0.6|0.9|0.7|148|Mortality|19976363|Leukemia|2002
<1|0.3|0.8|0.5|21|Mortality|3985102|Leukemia|2002
1-4|8.0|9.0|8.5|1220|Incidence|14396227|Leukemia|2002
10-14|2.6|3.0|2.8|544|Incidence|19533296|Leukemia|2002
15-19|2.6|3.1|2.8|535|Incidence|18815493|Leukemia|2002
5-9|3.6|4.1|3.9|713|Incidence|18503153|Leukemia|2002
<1|3.5|4.8|4.1|152|Incidence|3691140|Leukemia|2002
15-19|2.6|3.1|2.9|583|Incidence|20301027|Leukemia|2004
5-9|3.6|4.2|3.9|752|Incidence|19244948|Leukemia|2004
<1|3.8|5.1|4.4|176|Incidence|4020211|Leukemia|2004
1-4|0.7|1.0|0.8|130|Mortality|15969384|Other|2004
10-14|0.3|0.4|0.3|69|Mortality|21117454|Other|2004
15-19|0.6|0.9|0.7|151|Mortality|20702581|Other|2004
5-9|0.4|0.6|0.5|98|Mortality|19598833|Other|2004
<1|0.3|0.8|0.5|20|Mortality|4090884|Other|2004
1-4|0.7|1.0|0.9|136|Mortality|15551951|Other|2002
10-14|0.3|0.5|0.4|78|Mortality|21107836|Other|2002
15-19|0.6|0.9|0.7|148|Mortality|20361711|Other|2002
5-9|0.4|0.6|0.5|97|Mortality|19976363|Other|2002
<1|0.5|1.1|0.8|31|Mortality|3985102|Other|2002
1-4|4.1|4.7|4.4|687|Incidence|15688413|Other|2004
10-14|2.6|3.1|2.8|590|Incidence|20724858|Other|2004
15-19|8.4|9.2|8.8|1781|Incidence|20301027|Other|2004
5-9|1.4|1.8|1.6|301|Incidence|19244948|Other|2004
<1|11.0|13.2|12.1|486|Incidence|4020211|Other|2004
1-4|3.8|4.5|4.1|597|Incidence|14396227|Other|2002
10-14|2.4|2.9|2.6|511|Incidence|19533296|Other|2002
15-19|8.3|9.2|8.7|1642|Incidence|18815493|Other|2002
5-9|1.4|1.8|1.6|292|Incidence|18503153|Other|2002
<1|9.9|12.0|10.9|402|Incidence|3691140|Other|2002
1-4|0.1|0.2|0.2|24|Mortality|15969384|Soft Tissue|2004
10-14|0.1|0.3|0.2|42|Mortality|21117454|Soft Tissue|2004
15-19|0.2|0.4|0.3|66|Mortality|20702581|Soft Tissue|2004
5-9|0.1|0.2|0.1|28|Mortality|19598833|Soft Tissue|2004
<1|~|~|~|~|Mortality|4090884|Soft Tissue|2004
<1|~|~|~|~|Mortality|3985102|Acute Myeloid|2002
1-4|0.7|1.0|0.8|121|Incidence|14396227|Acute Myeloid|2002
10-14|0.6|0.8|0.7|133|Incidence|19533296|Acute Myeloid|2002
15-19|0.7|1.0|0.9|162|Incidence|18815493|Acute Myeloid|2002
5-9|0.3|0.5|0.4|79|Incidence|18503153|Acute Myeloid|2002
<1|0.9|1.7|1.3|47|Incidence|3691140|Acute Myeloid|2002
1-4|0.9|1.3|1.1|169|Incidence|15688413|Soft Tissue|2004
10-14|0.8|1.1|1.0|200|Incidence|20724858|Soft Tissue|2004
15-19|1.0|1.3|1.2|241|Incidence|20301027|Soft Tissue|2004
5-9|0.4|0.6|0.5|98|Incidence|19244948|Soft Tissue|2004
<1|2.7|3.8|3.2|129|Incidence|4020211|Soft Tissue|2004
1-4|0.2|0.3|0.3|41|Mortality|16200164|Acute Lymphocytic|2005
10-14|0.3|0.5|0.4|79|Mortality|20845086|Acute Lymphocytic|2005
15-19|0.3|0.5|0.4|79|Mortality|21019840|Acute Lymphocytic|2005
5-9|0.3|0.4|0.3|64|Mortality|19525557|Acute Lymphocytic|2005
<1|~|~|~|~|Mortality|4099610|Acute Lymphocytic|2005
1-4|~|~|~|~|Mortality|15969384|Bones and Joints|2004
10-14|0.2|0.3|0.3|57|Mortality|21117454|Bones and Joints|2004
15-19|0.5|0.7|0.6|114|Mortality|20702581|Bones and Joints|2004
5-9|~|~|~|~|Mortality|19598833|Bones and Joints|2004
<1|~|~|~|~|Mortality|4090884|Bones and Joints|2004
1-4|~|~|~|~|Mortality|15551951|Bones and Joints|2002
10-14|0.2|0.4|0.3|61|Mortality|21107836|Bones and Joints|2002
15-19|0.4|0.6|0.5|94|Mortality|20361711|Bones and Joints|2002
5-9|0.1|0.2|0.1|21|Mortality|19976363|Bones and Joints|2002
<1|~|~|~|~|Mortality|3985102|Bones and Joints|2002
1-4|0.1|0.3|0.2|30|Incidence|15688413|Bones and Joints|2004
10-14|1.3|1.6|1.5|304|Incidence|20724858|Bones and Joints|2004
15-19|1.3|1.7|1.5|302|Incidence|20301027|Bones and Joints|2004
5-9|0.4|0.6|0.5|101|Incidence|19244948|Bones and Joints|2004
<1|~|~|~|~|Incidence|4020211|Bones and Joints|2004
1-4|0.1|0.2|0.2|24|Incidence|14396227|Bones and Joints|2002
10-14|1.2|1.5|1.3|263|Incidence|19533296|Bones and Joints|2002
15-19|1.4|1.8|1.6|297|Incidence|18815493|Bones and Joints|2002
5-9|0.5|0.7|0.6|110|Incidence|18503153|Bones and Joints|2002
<1|~|~|~|~|Incidence|3691140|Bones and Joints|2002
1-4|3.9|4.6|4.2|639|Incidence|15151945|Other|2003
10-14|2.7|3.2|2.9|597|Incidence|20383692|Other|2003
15-19|8.2|9.1|8.7|1703|Incidence|19681033|Other|2003
5-9|1.1|1.5|1.3|244|Incidence|19012396|Other|2003
<1|10.4|12.6|11.5|446|Incidence|3882968|Other|2003
1-4|~|~|~|~|Mortality|15742383|Soft Tissue|2003
10-14|0.1|0.2|0.2|36|Mortality|21192613|Soft Tissue|2003
15-19|0.3|0.4|0.3|68|Mortality|20467671|Soft Tissue|2003
5-9|0.1|0.2|0.1|26|Mortality|19753885|Soft Tissue|2003
<1|~|~|~|~|Mortality|4031134|Soft Tissue|2003
1-4|0.9|1.2|1.0|158|Incidence|15151945|Soft Tissue|2003
10-14|0.8|1.0|0.9|182|Incidence|20383692|Soft Tissue|2003
15-19|1.1|1.4|1.2|242|Incidence|19681033|Soft Tissue|2003
5-9|0.4|0.6|0.5|97|Incidence|19012396|Soft Tissue|2003
<1|2.6|3.7|3.1|120|Incidence|3882968|Soft Tissue|2003
1-4|0.1|0.3|0.2|30|Incidence|13822338|Bones and Joints|1999
10-14|1.3|1.6|1.4|262|Incidence|18146881|Bones and Joints|1999
15-19|1.2|1.6|1.4|248|Incidence|17976823|Bones and Joints|1999
5-9|0.5|0.7|0.6|105|Incidence|18557028|Bones and Joints|1999
1-4|0.7|1.0|0.8|122|Mortality|15324231|Other|2001
10-14|0.3|0.4|0.3|70|Mortality|20892214|Other|2001
15-19|0.6|0.9|0.7|147|Mortality|20305228|Other|2001
5-9|0.3|0.5|0.4|88|Mortality|20234597|Other|2001
<1|0.2|0.7|0.4|17|Mortality|4025926|Other|2001
1-4|0.2|0.4|0.3|42|Mortality|15969384|Acute Lymphocytic|2004
10-14|0.3|0.4|0.3|72|Mortality|21117454|Acute Lymphocytic|2004
15-19|0.4|0.6|0.4|93|Mortality|20702581|Acute Lymphocytic|2004
5-9|0.3|0.5|0.4|83|Mortality|19598833|Acute Lymphocytic|2004
<1|~|~|~|~|Mortality|4090884|Acute Lymphocytic|2004
1-4|4.1|4.8|4.5|637|Incidence|14214314|Other|2001
10-14|2.5|2.9|2.7|522|Incidence|19360577|Other|2001
15-19|7.8|8.7|8.2|1547|Incidence|18791536|Other|2001
5-9|1.3|1.6|1.4|272|Incidence|18776213|Other|2001
<1|10.6|12.8|11.7|436|Incidence|3735453|Other|2001
1-4|7.1|8.0|7.5|1180|Incidence|15688413|Acute Lymphocytic|2004
10-14|1.7|2.0|1.8|381|Incidence|20724858|Acute Lymphocytic|2004
15-19|1.5|1.8|1.6|329|Incidence|20301027|Acute Lymphocytic|2004
5-9|3.0|3.5|3.2|622|Incidence|19244948|Acute Lymphocytic|2004
<1|1.6|2.4|2.0|79|Incidence|4020211|Acute Lymphocytic|2004
1-4|0.1|0.2|0.1|18|Mortality|15324231|Soft Tissue|2001
10-14|0.1|0.2|0.2|36|Mortality|20892214|Soft Tissue|2001
15-19|0.2|0.4|0.3|61|Mortality|20305228|Soft Tissue|2001
5-9|0.1|0.2|0.1|26|Mortality|20234597|Soft Tissue|2001
<1|~|~|~|~|Mortality|4025926|Soft Tissue|2001
1-4|0.3|0.4|0.3|55|Mortality|15969384|Acute Myeloid|2004
10-14|0.2|0.3|0.2|50|Mortality|21117454|Acute Myeloid|2004
15-19|0.2|0.4|0.3|64|Mortality|20702581|Acute Myeloid|2004
5-9|0.1|0.2|0.2|35|Mortality|19598833|Acute Myeloid|2004
<1|~|~|~|~|Mortality|4090884|Acute Myeloid|2004
1-4|1.0|1.4|1.2|174|Incidence|14214314|Soft Tissue|2001
10-14|0.7|1.0|0.9|169|Incidence|19360577|Soft Tissue|2001
15-19|0.9|1.2|1.1|204|Incidence|18791536|Soft Tissue|2001
5-9|0.4|0.6|0.5|86|Incidence|18776213|Soft Tissue|2001
<1|2.8|4.0|3.3|124|Incidence|3735453|Soft Tissue|2001
1-4|0.7|1.0|0.9|139|Incidence|15688413|Acute Myeloid|2004
10-14|0.5|0.8|0.6|133|Incidence|20724858|Acute Myeloid|2004
15-19|0.7|1.0|0.9|173|Incidence|20301027|Acute Myeloid|2004
5-9|0.4|0.6|0.5|87|Incidence|19244948|Acute Myeloid|2004
<1|1.1|1.8|1.4|57|Incidence|4020211|Acute Myeloid|2004
1-4|0.2|0.3|0.2|34|Mortality|15551951|Acute Lymphocytic|2002
10-14|0.3|0.5|0.4|91|Mortality|21107836|Acute Lymphocytic|2002
15-19|0.4|0.6|0.5|106|Mortality|20361711|Acute Lymphocytic|2002
5-9|0.3|0.5|0.4|82|Mortality|19976363|Acute Lymphocytic|2002
<1|~|~|~|~|Mortality|3985102|Acute Lymphocytic|2002
1-4|6.7|7.5|7.1|1019|Incidence|14396227|Acute Lymphocytic|2002
10-14|1.6|2.0|1.8|358|Incidence|19533296|Acute Lymphocytic|2002
15-19|1.4|1.8|1.6|300|Incidence|18815493|Acute Lymphocytic|2002
5-9|2.8|3.4|3.1|573|Incidence|18503153|Acute Lymphocytic|2002
<1|1.4|2.3|1.8|66|Incidence|3691140|Acute Lymphocytic|2002
1-4|0.2|0.4|0.3|46|Mortality|15551951|Acute Myeloid|2002
10-14|0.2|0.3|0.2|44|Mortality|21107836|Acute Myeloid|2002
15-19|0.3|0.5|0.4|78|Mortality|20361711|Acute Myeloid|2002
5-9|0.1|0.2|0.2|34|Mortality|19976363|Acute Myeloid|2002
1-4|0.1|0.2|0.2|22|Incidence|14214314|Bones and Joints|2001
10-14|1.2|1.6|1.4|268|Incidence|19360577|Bones and Joints|2001
15-19|1.5|1.9|1.7|318|Incidence|18791536|Bones and Joints|2001
5-9|0.5|0.7|0.6|106|Incidence|18776213|Bones and Joints|2001
<1|~|~|~|~|Incidence|3735453|Bones and Joints|2001
1-4|0.7|1.0|0.8|133|Mortality|15742383|Leukemia|2003
10-14|0.8|1.0|0.9|186|Mortality|21192613|Leukemia|2003
15-19|0.8|1.0|0.9|183|Mortality|20467671|Leukemia|2003
5-9|0.7|0.9|0.8|156|Mortality|19753885|Leukemia|2003
<1|0.5|1.1|0.7|30|Mortality|4031134|Leukemia|2003
1-4|7.6|8.5|8.0|1215|Incidence|15151945|Leukemia|2003
10-14|2.4|2.8|2.6|525|Incidence|20383692|Leukemia|2003
15-19|2.4|2.9|2.7|526|Incidence|19681033|Leukemia|2003
5-9|3.5|4.1|3.8|722|Incidence|19012396|Leukemia|2003
<1|3.6|5.0|4.3|166|Incidence|3882968|Leukemia|2003
1-4|0.9|1.2|1.0|155|Mortality|15324231|Leukemia|2001
10-14|0.7|0.9|0.8|170|Mortality|20892214|Leukemia|2001
15-19|1.0|1.3|1.1|225|Mortality|20305228|Leukemia|2001
5-9|0.6|0.9|0.8|153|Mortality|20234597|Leukemia|2001
<1|0.4|0.9|0.6|25|Mortality|4025926|Leukemia|2001
1-4|0.6|0.9|0.7|118|Mortality|15742383|Other|2003
10-14|0.3|0.4|0.3|69|Mortality|21192613|Other|2003
15-19|0.6|0.8|0.7|136|Mortality|20467671|Other|2003
5-9|0.4|0.6|0.5|101|Mortality|19753885|Other|2003
<1|0.4|0.9|0.6|23|Mortality|4031134|Other|2003
1-4|8.5|9.5|9.0|1279|Incidence|14214314|Leukemia|2001
10-14|2.7|3.2|3.0|575|Incidence|19360577|Leukemia|2001
15-19|2.6|3.1|2.8|534|Incidence|18791536|Leukemia|2001
5-9|3.5|4.1|3.8|707|Incidence|18776213|Leukemia|2001
<1|3.4|4.8|4.1|152|Incidence|3735453|Leukemia|2001
5-9|3.0|3.5|3.2|609|Incidence|19012396|Acute Lymphocytic|2003
<1|1.5|2.3|1.9|72|Incidence|3882968|Acute Lymphocytic|2003
1-4|0.8|1.2|1.0|140|Incidence|14042091|Soft Tissue|2000
10-14|0.7|1.0|0.8|159|Incidence|18847598|Soft Tissue|2000
15-19|1.1|1.4|1.2|226|Incidence|18475345|Soft Tissue|2000
5-9|0.5|0.7|0.6|105|Incidence|18755372|Soft Tissue|2000
<1|2.5|3.7|3.1|109|Incidence|3528687|Soft Tissue|2000
1-4|0.2|0.3|0.2|38|Mortality|15742383|Acute Myeloid|2003
10-14|0.2|0.3|0.3|55|Mortality|21192613|Acute Myeloid|2003
15-19|0.2|0.4|0.3|65|Mortality|20467671|Acute Myeloid|2003
5-9|0.1|0.3|0.2|39|Mortality|19753885|Acute Myeloid|2003
<1|~|~|~|~|Mortality|4031134|Acute Myeloid|2003
1-4|0.2|0.4|0.3|41|Mortality|15324231|Acute Lymphocytic|2001
10-14|0.3|0.5|0.4|78|Mortality|20892214|Acute Lymphocytic|2001
15-19|0.4|0.6|0.5|105|Mortality|20305228|Acute Lymphocytic|2001
5-9|0.3|0.5|0.4|84|Mortality|20234597|Acute Lymphocytic|2001
<1|~|~|~|~|Mortality|4025926|Acute Lymphocytic|2001
1-4|0.7|1.0|0.9|129|Incidence|15151945|Acute Myeloid|2003
10-14|0.5|0.7|0.6|127|Incidence|20383692|Acute Myeloid|2003
15-19|0.7|0.9|0.8|156|Incidence|19681033|Acute Myeloid|2003
5-9|0.3|0.5|0.4|71|Incidence|19012396|Acute Myeloid|2003
<1|1.0|1.8|1.3|52|Incidence|3882968|Acute Myeloid|2003
1-4|7.2|8.1|7.6|1084|Incidence|14214314|Acute Lymphocytic|2001
10-14|1.8|2.2|2.0|390|Incidence|19360577|Acute Lymphocytic|2001
15-19|1.4|1.8|1.6|295|Incidence|18791536|Acute Lymphocytic|2001
5-9|2.9|3.4|3.1|583|Incidence|18776213|Acute Lymphocytic|2001
<1|1.5|2.4|1.9|70|Incidence|3735453|Acute Lymphocytic|2001
1-4|0.4|0.6|0.5|73|Mortality|15324231|Acute Myeloid|2001
10-14|0.2|0.3|0.2|46|Mortality|20892214|Acute Myeloid|2001
15-19|0.3|0.4|0.3|70|Mortality|20305228|Acute Myeloid|2001
5-9|0.1|0.2|0.2|31|Mortality|20234597|Acute Myeloid|2001
<1|~|~|~|~|Mortality|4025926|Acute Myeloid|2001
1-4|0.7|1.0|0.8|118|Incidence|14214314|Acute Myeloid|2001
10-14|0.6|0.8|0.7|130|Incidence|19360577|Acute Myeloid|2001
15-19|0.7|1.0|0.8|153|Incidence|18791536|Acute Myeloid|2001
5-9|0.3|0.5|0.4|78|Incidence|18776213|Acute Myeloid|2001
<1|1.0|1.8|1.3|50|Incidence|3735453|Acute Myeloid|2001
1-4|~|~|~|~|Mortality|15742383|Bones and Joints|2003
10-14|0.2|0.4|0.3|64|Mortality|21192613|Bones and Joints|2003
15-19|0.4|0.6|0.5|104|Mortality|20467671|Bones and Joints|2003
5-9|~|~|~|~|Mortality|19753885|Bones and Joints|2003
<1|~|~|~|~|Mortality|4031134|Bones and Joints|2003
1-4|0.2|0.3|0.2|34|Incidence|15151945|Bones and Joints|2003
10-14|1.2|1.5|1.4|277|Incidence|20383692|Bones and Joints|2003
15-19|1.3|1.7|1.5|293|Incidence|19681033|Bones and Joints|2003
5-9|0.4|0.6|0.5|93|Incidence|19012396|Bones and Joints|2003
<1|~|~|~|~|Incidence|3882968|Bones and Joints|2003
1-4|~|~|~|~|Mortality|15324231|Bones and Joints|2001
10-14|0.3|0.4|0.3|72|Mortality|20892214|Bones and Joints|2001
15-19|0.4|0.6|0.5|101|Mortality|20305228|Bones and Joints|2001
5-9|~|~|~|~|Mortality|20234597|Bones and Joints|2001
<1|~|~|~|~|Mortality|4025926|Bones and Joints|2001
1-4|0.8|1.1|0.9|137|Mortality|15331809|Leukemia|2000
10-14|0.7|1.0|0.8|173|Mortality|20620197|Leukemia|2000
15-19|1.0|1.4|1.2|242|Mortality|20261514|Leukemia|2000
5-9|0.6|0.8|0.7|142|Mortality|20476523|Leukemia|2000
<1|0.7|1.4|1.0|38|Mortality|3855642|Leukemia|2000
1-4|8.0|8.9|8.4|1183|Incidence|14042091|Leukemia|2000
10-14|2.2|2.7|2.5|462|Incidence|18847598|Leukemia|2000
15-19|2.5|3.0|2.8|509|Incidence|18475345|Leukemia|2000
5-9|3.5|4.1|3.8|711|Incidence|18755372|Leukemia|2000
<1|4.0|5.4|4.6|164|Incidence|3528687|Leukemia|2000
1-4|0.7|1.0|0.9|135|Mortality|15331809|Other|2000
10-14|0.3|0.5|0.4|76|Mortality|20620197|Other|2000
15-19|0.6|0.8|0.7|138|Mortality|20261514|Other|2000
5-9|0.4|0.6|0.5|98|Mortality|20476523|Other|2000
<1|0.4|0.9|0.6|24|Mortality|3855642|Other|2000
1-4|3.6|4.2|3.9|546|Incidence|14042091|Other|2000
10-14|2.2|2.6|2.4|448|Incidence|18847598|Other|2000
15-19|7.4|8.2|7.8|1440|Incidence|18475345|Other|2000
5-9|1.1|1.4|1.2|228|Incidence|18755372|Other|2000
<1|8.9|11.0|9.9|351|Incidence|3528687|Other|2000
1-4|0.1|0.2|0.1|20|Mortality|15331809|Soft Tissue|2000
10-14|0.1|0.2|0.1|27|Mortality|20620197|Soft Tissue|2000
15-19|0.3|0.5|0.4|73|Mortality|20261514|Soft Tissue|2000
5-9|0.0|0.1|0.1|17|Mortality|20476523|Soft Tissue|2000
<1|~|~|~|~|Mortality|3855642|Soft Tissue|2000
1-4|0.7|1.0|0.8|116|Incidence|14042091|Acute Myeloid|2000
10-14|0.4|0.6|0.5|87|Incidence|18847598|Acute Myeloid|2000
15-19|0.7|1.0|0.8|152|Incidence|18475345|Acute Myeloid|2000
5-9|0.3|0.5|0.4|74|Incidence|18755372|Acute Myeloid|2000
<1|1.0|1.8|1.3|47|Incidence|3528687|Acute Myeloid|2000
1-4|~|~|~|~|Mortality|15331809|Bones and Joints|2000
10-14|0.2|0.4|0.3|62|Mortality|20620197|Bones and Joints|2000
15-19|0.4|0.6|0.5|98|Mortality|20261514|Bones and Joints|2000
5-9|0.1|0.1|0.1|19|Mortality|20476523|Bones and Joints|2000
<1|~|~|~|~|Mortality|3855642|Bones and Joints|2000
1-4|0.1|0.2|0.1|20|Incidence|14042091|Bones and Joints|2000
10-14|1.2|1.5|1.4|255|Incidence|18847598|Bones and Joints|2000
15-19|1.2|1.6|1.4|257|Incidence|18475345|Bones and Joints|2000
5-9|0.4|0.6|0.5|98|Incidence|18755372|Bones and Joints|2000
<1|~|~|~|~|Incidence|3528687|Bones and Joints|2000
1-4|0.7|1.0|0.8|129|Mortality|15339782|Other|1999
10-14|0.3|0.4|0.3|68|Mortality|20213364|Other|1999
15-19|0.5|0.8|0.6|127|Mortality|20084602|Other|1999
5-9|0.4|0.6|0.5|108|Mortality|20606460|Other|1999
<1|0.4|0.9|0.6|23|Mortality|3795762|Other|1999
1-4|3.6|4.3|3.9|543|Incidence|13822338|Other|1999
10-14|2.1|2.6|2.3|423|Incidence|18146881|Other|1999
15-19|7.4|8.3|7.8|1411|Incidence|17976823|Other|1999
5-9|1.0|1.3|1.1|213|Incidence|18557028|Other|1999
<1|9.8|12.0|10.9|371|Incidence|3417510|Other|1999
